ALLO Stock-Based Compensation
Allogene Therapeutics Inc · Stock-Based Compensation
ALLO Stock-Based Compensation
Latest reported$37.49Mperiod ending
ALLO TTM Stock-Based Comp ($18.57M → $37.49M)
TTM stock-based compensation
High-resolution chart · PNG
ALLO stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 37,492,000 | |
| 33,737,000 | |
| 37,642,000 | |
| 42,385,000 | |
| 47,120,000 | |
| 51,994,000 | |
| 51,743,000 | |
| 54,103,000 | |
| 56,070,000 | |
| 59,105,000 | |
| 65,951,000 | |
| 67,964,000 | |
| 73,758,000 | |
| 80,055,000 | |
| 83,600,000 | |
| 88,390,000 | |
| 88,098,000 | |
| 86,341,000 | |
| 80,818,000 | |
| 75,235,000 | |
| 72,202,000 | |
| 67,838,000 | |
| 65,261,000 | |
| 62,682,000 | |
| 57,694,000 | |
| 52,411,000 | |
| 46,063,000 | |
| 38,060,000 | |
| 29,864,000 | |
| 26,433,000 | |
| 18,566,000 | |
| 12,695,000 |